Am J Gastroenterol
- HUME SJ, Holmes JA, Thompson AJ
Individualizing the Approach to Stopping Nucleos(t)ide Analogs: Can We Use a Low
HBsAg Threshold to Predict a High Chance of Functional Cure and Minimal Risk of
Hepatic Decompensation?
Am J Gastroenterol. 2024 Apr 15. doi: 10.14309/ajg.0000000000002766.
Ann Intern Med
- ANVARI S, Dadgar K, Galts C, Bretthauer M, et al
Gastroenterology/Hepatology: What You May Have Missed in 2023.
Ann Intern Med. 2024 Apr 16. doi: 10.7326/M24-0505.
Biochem Biophys Res Commun
- CAO Y, Wang S, Zhang M, Lai B, et al
PFKFB3-mediated glycolysis in hepatic stellate cells promotes liver regeneration.
Biochem Biophys Res Commun. 2024;712-713:149958.
BMC Cancer
- HAO X, Xu L, Lan X, Li B, et al
Impact of hepatic inflammation and fibrosis on the recurrence and long-term
survival of hepatitis B virus-related hepatocellular carcinoma patients after
hepatectomy.
BMC Cancer. 2024;24:475.
- ZONG K, Lin C, Luo K, Deng Y, et al
Ferroptosis-related lncRNA NRAV affects the prognosis of hepatocellular carcinoma
via the miR-375-3P/SLC7A11 axis.
BMC Cancer. 2024;24:496.
- HUANG Y, Chen D, Bai Y, Zhang Y, et al
ESCO2's oncogenic role in human tumors: a pan-cancer analysis and experimental
validation.
BMC Cancer. 2024;24:452.
- YOU X, Qiu J, Li Q, Zhang Q, et al
Astragaloside IV-PESV inhibits prostate cancer tumor growth by restoring gut
microbiota and microbial metabolic homeostasis via the AGE-RAGE pathway.
BMC Cancer. 2024;24:472.
- CHANG X, Li X, Sun P, Li Z, et al
HAIC Combined with lenvatinib plus PD-1 versus lenvatinib Plus PD-1 in patients
with high-risk advanced HCC: a real-world study.
BMC Cancer. 2024;24:480.
- LI Y, Chen Z, Tian S, Han X, et al
Stereotactic ablative brachytherapy versus percutaneous microwave ablation as
salvage treatments for lung oligometastasis from colorectal cancer.
BMC Cancer. 2024;24:481.
BMC Gastroenterol
- XIE H, Hong T, Liu W, Jia X, et al
Interpretable machine learning-based clinical prediction model for predicting
lymph node metastasis in patients with intrahepatic cholangiocarcinoma.
BMC Gastroenterol. 2024;24:137.
Br J Surg
- AKABANE M, Bekki Y, Imaoka Y, Inaba Y, et al
Impact of donor characteristics on hepatocellular carcinoma recurrence after
liver transplantation.
Br J Surg. 2024;111:znae080.
- JOLIAT GR, de Man R, Rijckborst V, Cimino M, et al
Long-term outcomes of ruptured hepatocellular carcinoma: international
multicentre study.
Br J Surg. 2024;111:znae093.
Cancer
- NIERENGARTEN MB
Global phase 3 results show that bevacizumab with immunotherapy has activity in
liver cancer.
Cancer. 2024;130:1547-1548.
Cancer Res
- LIU X, Wang X, Yang Q, Luo L, et al
Th17 cells secrete TWEAK to trigger epithelial-mesenchymal transition and promote
colorectal cancer liver metastasis.
Cancer Res. 2024 Feb 9. doi: 10.1158/0008-5472.CAN-23-2123.
Dig Dis Sci
- MCCURDY H, Nobbe A, Scott D, Patton H, et al
Organizational and Implementation Factors Associated with Cirrhosis Care in the
Veterans Health Administration.
Dig Dis Sci. 2024 Apr 14. doi: 10.1007/s10620-024-08409.
- BEHARI J
Spleen Stiffness Measurement in Metabolic Dysfunction-Associated Steatotic Liver
Disease-Value Added or Work in Progress?
Dig Dis Sci. 2024;69:1093-1095.
- WILLIAMS EE, Mladenovic A, Ranginani D, Weber R, et al
Role of Spleen Stiffness Measurement in the Evaluation of Metabolic
Dysfunction-Associated Steatotic Liver Disease.
Dig Dis Sci. 2024;69:1444-1453.
- GU Y, Chen G, Ning X
Homeobox Protein BarH-like 1 Promotes Gastric Cancer Progression by Activating
Coiled-Coil Domain-Containing Protein 178.
Dig Dis Sci. 2024 Feb 15. doi: 10.1007/s10620-024-08312.
- POP A, Halegoua-DeMarzio D, Barnhart H, Kleiner D, et al
Amiodarone and Dronedarone Causes Liver Injury with Distinctly Different Clinical
Presentations.
Dig Dis Sci. 2024;69:1479-1487.
- KHAMSEH ME, Malek M, Jahangiri S, Nobarani S, et al
Insulin Resistance/Sensitivity Measures as Screening Indicators of
Metabolic-Associated Fatty Liver Disease and Liver Fibrosis.
Dig Dis Sci. 2024;69:1430-1443.
Gastrointest Endosc
- MATSUMOTO K, Kato H, Matsumi A, Miyamoto K, et al
Detection of residual stones by peroral direct cholangioscopy in patients with
intrahepatic stones after hepaticojejunostomy: A prospective study (with video).
Gastrointest Endosc. 2024 Apr 15:S0016-5107(24)00234.
Gut
- SUDDLE A, Reeves H, Hubner R, Marshall A, et al
British Society of Gastroenterology guidelines for the management of
hepatocellular carcinoma in adults.
Gut. 2024 Apr 16:gutjnl-2023-331695. doi: 10.1136/gutjnl-2023-331695.
- LIU J, MacNaughtan J, Kerbert AJC, Portlock T, et al
Clinical, experimental and pathophysiological effects of Yaq-001: a non-absorbab
le, gut-restricted adsorbent in models and patients with cirrhosis.
Gut. 2024 Apr 15:gutjnl-2023-330699. doi: 10.1136/gutjnl-2023-330699.
Hepatology
- LENZ D, Schlieben LD, Shimura M, Bianzano A, et al
Genetic landscape of pediatric acute liver failure of indeterminate origin.
Hepatology. 2024;79:1075-1087.
- GISH RG, Wong RJ, Di Tanna GL, Kaushik A, et al
Association between hepatitis delta virus with liver morbidity and mortality: A
systematic literature review and meta-analysis.
Hepatology. 2023 Oct 23. doi: 10.1097/HEP.0000000000000642.
- AJMERA V, Tesfai K, Sandoval E, Lopez S, et al
Validation of AGA clinical care pathway and AASLD practice guidance for
nonalcoholic fatty liver disease in a prospective cohort of patients with type 2
diabetes.
Hepatology. 2024;79:1098-1106.
- TONIUTTO P, Shalaby S, Mameli L, Morisco F, et al
Role of sex in liver tumor occurrence and clinical outcomes: A comprehensive
review.
Hepatology. 2024;79:1141-1157.
- SANTOS AA, Delgado TC, Marques V, Ramirez-Moncayo C, et al
Spatial metabolomics and its application in the liver.
Hepatology. 2024;79:1158-1179.
- LEE YT, Tseng HR, Yang JD
Clonal hematopoiesis of indeterminate potential and risk of hepatocellular
carcinoma: New kids on the block.
Hepatology. 2024 Apr 19. doi: 10.1097/HEP.0000000000000898.
- GUO C, Liu Z, Fan H, Wang H, et al
Machine learning-based plasma metabolomic profiles for predicting long-term
complications of cirrhosis.
Hepatology. 2024 Apr 17. doi: 10.1097/HEP.0000000000000879.
-
Erratum: Overexpressed-eIF3I interacted and activated oncogenic Akt1 is a
theranostic target in human hepatocellular carcinoma.
Hepatology. 2024;79:E150-E151.
- HAZARI Y, Chevet E, Bailly-Maitre B, Hetz C, et al
ER stress signaling at the interphase between MASH and hepatocellular carcinoma.
Hepatology. 2024 Apr 16. doi: 10.1097/HEP.0000000000000893.
- PRZYBYSZEWSKI EM, Bhan I, Yarze JC
Letter to the Editor: On the use of non-selective beta blockers in cirrhosis.
Hepatology. 2024 Apr 16. doi: 10.1097/HEP.0000000000000888.
- GARCIA-TSAO G, Kaplan DE
Reply: On the use of non-selective beta blockers in cirrhosis.
Hepatology. 2024 Apr 16. doi: 10.1097/HEP.0000000000000889.
- VOLK ML
Innovations in Healthcare Delivery for Patients with Cirrhosis.
Hepatology. 2024 Apr 16. doi: 10.1097/HEP.0000000000000892.
- KANWAL F, Neuschwander-Tetri BA, Loomba R, Rinella ME, et al
Metabolic dysfunction-associated steatotic liver disease: Update and impact of
new nomenclature on the American Association for the Study of Liver Diseases
practice guidance on nonalcoholic fatty liver disease.
Hepatology. 2024;79:1212-1219.
- NABI O, Lapidus N, Boursier J, de Ledinghen V, et al
Reply: Concerns regarding the use of Fatty Liver Index in studies of lean NAFLD.
Hepatology. 2024;79:E130-E131.
- ZAHRAWI FM, Mehal WZ
Letter to the Editor: Concerns regarding the use of fatty liver index in studies
of lean NAFLD.
Hepatology. 2024;79:E129.
- STOCKDALE AJ, Degasperi E
HDV RNA and liver disease progression: What do we know?
Hepatology. 2024;79:983-985.
- CORPECHOT C, Lemoinne S, Soret PA, Chazouilleres O, et al
Reply: Improving access to transient elastography data for Real-World Prognostic
Applications in primary biliary cholangitis.
Hepatology. 2023 Dec 27. doi: 10.1097/HEP.0000000000000746.
- WIEGAND J, Franke A, Stein K, Trautwein C, et al
Letter to the Editor: Improving access to transient elastography data for
real-world prognostic applications in primary biliary cholangitis.
Hepatology. 2023 Dec 27. doi: 10.1097/HEP.0000000000000744.
- DESERT R, Foucher F, Guillout M, Nieto N, et al
Reply: Intratumor fibrotic HCC, a subtype matching the Hoshida S1 subclass?
Hepatology. 2024;79:E141-E143.
- WANG TC, Xiao YD, Zhou P
Letter to the Editor: Intratumor fibrotic HCC, a subtype matching the Hoshida S1
subclass?
Hepatology. 2024;79:E140.
- LIU H, Li H, Wang DX, Li T, et al
Letter to the Editor: Diagnostic accuracy of AGILE 3+ score for advanced fibrosis
in patients with NAFLD: A systematic review and meta-analysis.
Hepatology. 2024;79:E144-E145.
- DALBENI A, Mantovani A, Lombardi R, Ravaioli F, et al
Reply: Diagnostic accuracy of AGILE3+ score for advanced fibrosis in patients
with non-alcoholic fatty liver disease: A systematic review and meta-analysis.
Hepatology. 2024;79:E146-E147.
- KIRK FT, Munk DE, Swenson ES, Quicquaro AM, et al
Effects of trientine and penicillamine on intestinal copper uptake: A mechanistic
64 Cu PET/CT study in healthy humans.
Hepatology. 2024;79:1065-1074.
- SQUIRES JE, Horslen SP
Incorporation of genetic testing into the diagnostic algorithms of PALF: The time
is now.
Hepatology. 2024;79:970-972.
- DALBENI A, Lombardi R, Henrique M, Zoncape M, et al
Diagnostic accuracy of AGILE 3+ score for advanced fibrosis in patients with
NAFLD: A systematic review and meta-analysis.
Hepatology. 2024;79:1107-1116.
Indian J Gastroenterol
- AGARWAL S, Sharma S, Grover I, Singh N, et al
Longitudinal changes in bone mineral density may be associated with long-term
survival in patients with cirrhosis: A proof of concept of study.
Indian J Gastroenterol. 2024 Apr 15. doi: 10.1007/s12664-023-01504.
J Gastroenterol Hepatol
- LOON E, Narvaez-Barbecho C, Ortiz JP, Balderramo D, et al
Impact of self-reported ancestry on the epidemiology of hepatocellular carcinoma.
J Gastroenterol Hepatol. 2024 Apr 13. doi: 10.1111/jgh.16578.
PLoS Genet
- MA RK, Tsai PY, Farghli AR, Shumway A, et al
DNAJB1-PRKACA fusion protein-regulated LINC00473 promotes tumor growth and alters
mitochondrial fitness in fibrolamellar carcinoma.
PLoS Genet. 2024;20:e1011216.
PLoS One
- PASTROVIC F, Novak R, Grgurevic I, Hrkac S, et al
Serum proteomic profiling of patients with compensated advanced chronic liver
disease with and without clinically significant portal hypertension.
PLoS One. 2024;19:e0301416.
- BAEK M, Kim M, Choi HI, Binas B, et al
Identification of differentially expressed mRNA/lncRNA modules in acutely
regorafenib-treated sorafenib-resistant Huh7 hepatocellular carcinoma cells.
PLoS One. 2024;19:e0301663.
- GURUN M, Brennan P, Handjiev S, Khatib A, et al
Increased risk of chronic kidney disease and mortality in a cohort of people
diagnosed with metabolic dysfunction associated steatotic liver disease with
hepatic fibrosis.
PLoS One. 2024;19:e0299507.
- CHAVEZ-TAPIA NC, Sanchez-Jimenez BA, Vidana-Perez D, Corrales-Rosas B, et al
Predictors for liver fibrosis in non-alcoholic patients with psoriatic diseases:
A multicenter cross sectional-study.
PLoS One. 2024;19:e0290632.
- WU T, Yang H, Li J, Fang H, et al
Jolkinolide B inhibits the progression of hepatocellular carcinoma by regulating
Musashi-2 protein.
PLoS One. 2024;19:e0299920.
- GABUZA K, Mabuda TI, Patel O, Khuboni N, et al
Afriplex GRTTM extract attenuates hepatic steatosis in an in vitro model of
NAFLD.
PLoS One. 2024;19:e0297572.
Proc Natl Acad Sci U S A
- GU L, Du Y, Chen J, Hasan MN, et al
Cullin 3 RING E3 ligase inactivation causes NRF2-dependent NADH reductive stress,
hepatic lipodystrophy, and systemic insulin resistance.
Proc Natl Acad Sci U S A. 2024;121:e2320934121.
Radiology
- LYU L, Xu P
Hepatic CT Perfusion in Budd-Chiari Syndrome before and after Intervention.
Radiology. 2024;311:e232426.
Semin Liver Dis
- BECH KT, Lindvig KP, Thiele M, Castera L, et al
Algorithms for Early Detection of Silent Liver Fibrosis in the Primary Care
Setting.
Semin Liver Dis. 2024;44:23-34.
- EL-KASSAS M, Awad A, Elbadry M, Arab JP, et al
Tailored Model of Care for Patients with Metabolic Dysfunction-Associated
Steatotic Liver Disease.
Semin Liver Dis. 2024;44:54-68.
- BESSONE F, Hillotte GL, Ahumada N, Jaureguizahar F, et al
UDCA for Drug-Induced Liver Disease: Clinical and Pathophysiological Basis.
Semin Liver Dis. 2024;44:1-22.
- TUTUSAUS A, Morales A, Garcia de Frutos P, Mari M, et al
GAS6/TAM Axis as Therapeutic Target in Liver Diseases.
Semin Liver Dis. 2024;44:99-114.
- MOUZAKI M, Woo JG, Divanovic S
Gestational and Developmental Contributors of Pediatric MASLD.
Semin Liver Dis. 2024;44:43-53.
- CANIVET CM, Boursier J, Loomba R
New Nomenclature for Nonalcoholic Fatty Liver Disease: Understanding Metabolic
Dysfunction-Associated Steatotic Liver Disease, Metabolic Dysfunction- and
Alcohol-Associated Liver Disease, and Their Implications in Clinical Practice.
Semin Liver Dis. 2024;44:35-42.
- ROMERO-GOMEZ M, Arab JP, Oliveira CP, Hernandez M, et al
Is There a Safe Alcohol Consumption Limit for the General Population and in
Patients with Liver Disease?
Semin Liver Dis. 2024;44:69-78.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016